Unverified50% confidenceFactExact time
As of 2024, the FDA has approved more than 800 AI/ML medical devices, with nearly all approvals positioning them as assistive diagnostic tools rather than independent decision-making systems.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
9/9/2026
First Seen
Valid until: 12/8/2026
Sources
Related Entities
Related Claims
UnverifiedUnder the major global regulatory frameworks, medical AI products are classified as Software as a Medical Device (SaMD); the U.S. FDA requires clearance through the 510(k) or PMA process, China's NMPA requires completion of Class III medical device registration, and the EU regulates them through the MDR.72% similarUnverifiedThe U.S. FDA classifies digital mental health tools into two categories: 'Software as a Medical Device' (SaMD) and 'General Wellness Software,' with the former requiring rigorous clinical validation and the latter being virtually unregulated.64% similarUnverifiedThe National Medical Products Administration (NMPA) has included medical AI software under the scope of medical device management, categorizing it as Class II or Class III medical devices for approval based on risk level.63% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/884323API
curl https://kongchang.com/api/v1/knowledge/claims/884323MCP
get_claim(id=884323)